Stock Market Update - January 9, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. ANPA - Rich Sparkle Holdings Limited Ordinary Shares
Price: $86.85 | Change: +258.88% ($62.65)
ANPA:NASDAQ rocketed up with an impressive 258.88% gain following a flurry of strategic announcements on January 9, 2026. Rich Sparkle Holdings Limited revealed plans to acquire Step Distinctive Limited for a staggering US$975 million, paid in shares. This significant move thrusts Rich Sparkle into the booming e-commerce live streaming sector.
What made this acquisition particularly interesting for investors is that Step Distinctive's live streaming operations are led by the renowned TikTok influencer, Serigne Khabane Lame, who will continue at the helm. This positions ANPA squarely in a high-growth market, leveraging established capabilities and a famous personality. Additionally, the company secured an extra US$39 million through a private placement for general working capital.
This powerful combination of entering a trending, high-growth market with an influential figure and bolstering financial flexibility clearly fueled the dramatic surge in ANPA's stock price.
2. NBY - NovaBay Pharmaceuticals, Inc.
Price: $19.16 | Change: +102.54% ($9.7)
NBY soared by an impressive 102.54% in a single day, capping off a two-week period of substantial gains. This dramatic surge for NovaBay Pharmaceuticals, Inc. was primarily driven by significant corporate developments, most notably the announcement of CEO David Lazar's resignation.
The market reacted positively to this leadership change and associated strategic restructuring, which included the transfer of Lazar's stock rights to new investors. This move seems to be perceived by investors as a step toward strengthening the company's financial health and future prospects, building on NovaBay's already strong 390.34% revenue growth over the past year.
It's a clear illustration of how major corporate shifts, even a CEO departure, can sometimes be viewed as a positive catalyst by the market, especially when combined with new investment and a solid foundation of past financial performance.
3. VLN - Valens Semiconductor Ltd.
Price: $2.48 | Change: +58.97% ($0.92)
VLN saw a significant jump of 58.97% recently, fueled by exciting news in the automotive and machine vision sectors. Valens Semiconductor, known for its high-performance connectivity solutions, announced several breakthroughs for its MIPI A-PHY compliant chipsets around January 2026.
The company secured its fourth global design win, bringing its VA7000 chipsets to a major car manufacturer for Advanced Driver Assistance Systems (ADAS) in China, with production starting in 2027. This highlights the growing importance of MIPI A-PHY as a key standard for future car designs. Additionally, Valens unveiled the automotive market's first production-ready MIPI A-PHY-enabled electronic mirror and a new platform for machine vision cameras at CES 2026. These developments not only reinforce Valens' position as a leader in this critical technology but also signal increasing industry momentum for the MIPI A-PHY standard across various applications, from smarter cars to industrial imaging.
4. ZVSA - ZyVersa Therapeutics, Inc.
Price: $0.2652 | Change: +56.18% ($0.0954)
ZVSA caught attention with a significant gain of 56.18% around January 10, 2026. This upward move wasn't driven by specific company news, like a new drug approval or partnership announcement from ZyVersa Therapeutics, Inc.
Instead, the surge appears to be part of a broader "January Rally," a market phenomenon where various stocks experience gains at the beginning of the year. ZyVersa's historically low trading price and volatility may have made it particularly susceptible to increased speculative buying during this general market upturn.
What makes ZVSA interesting for the long term, despite this particular rally not being tied to direct news, is its ongoing clinical development. The company is advancing VAR 200 for kidney diseases, with preliminary Phase 2a data expected in late 2025/early 2026, and its IC 100 program for obesity and inflammatory diseases is slated to begin Phase 1 trials in the first half of 2026.
5. GP - GreenPower Motor Company Inc.
Price: $1.24 | Change: +51.04% ($0.419)
GP saw an impressive 51.04% gain after GreenPower Motor Company announced plans for a new advanced electric vehicle (EV) manufacturing facility in Santa Teresa, New Mexico, around January 10, 2026. This 135,000 sq. ft. facility will serve as its North American operations base and U.S. corporate headquarters, backed by a substantial $14.6 million incentive package from the State of New Mexico.
Further bolstering the news, GreenPower secured US$10 million in new financing from credit facilities and family offices, along with additional standby facilities. This capital aims to strengthen the company's liquidity and accelerate the production of its all-electric vehicles to fulfill existing customer orders.
This combination of a strategic expansion with significant government incentives and fresh financing suggests a strong push by GreenPower to scale up its operations and meet the increasing demand in the competitive EV market, marking a clear path forward for the company.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.